Modern treatment programs for primary Hodgkin's lymphoma and reasons of treatment failure
Between 1975 and 2005, 566patients (pts) with primary Hodgkin s lymphoma were treated at N.N. Blokhin Cancer Research Center. We analyzed an influence of treatment programs execution on long-term results based on data of treatment efficacy. Median follow-up period was 58 months (range 5 months — 25...
Main Authors: | E. A. Demina, G. S. Tumyan, E. N. Unukova, N. E. Kondratieva, A. G. Borodkina, T. I. Zaitseva, O. M. Meluzova, S. V. Shiriaev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2022-11-01
|
Series: | Онкогематология |
Subjects: | |
Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/640 |
Similar Items
-
The effectiveness of chemo-radiotherapy programs of last generation in patients with hodgkin's lymphoma
by: E. A. Demina, et al.
Published: (2022-11-01) -
Brentuximab vedotin is the first target drug in the treatment of hodgkin lymphoma
by: G. S. Tumyan
Published: (2018-11-01) -
Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
by: Irene Biasoli, et al.
Published: (2023-11-01) -
The Treatment of Non-Hodgkin's Lymphomas
by: David J. Straus
Published: (2023-08-01) -
Angioimmunoblastic T-Cell Lymphoma after Treatment of Classic Hodgkin Lymphoma: A Case Report
by: Ken Tanaka, et al.
Published: (2023-11-01)